NASDAQ:KALA - Kala Pharmaceuticals SEC Filings & 10K Form

$5.54
-0.08 (-1.42 %)
(As of 06/19/2019 08:51 AM ET)
Today's Range
$5.50
Now: $5.54
$5.69
50-Day Range
$4.99
MA: $6.02
$7.92
52-Week Range
$4.03
Now: $5.54
$14.95
Volume172,355 shs
Average Volume178,529 shs
Market Capitalization$187.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91

SEC Filings

Kala Pharmaceuticals (NASDAQ:KALA) SEC Filings

DateFilerForm TypeView
06/07/2019
3:03 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:02 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/03/2019
9:41 AM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2019
3:36 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2019
6:06 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/12/2019
3:08 PM
Kala Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/12/2019
3:02 PM
Kala Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/12/2019
7:42 AM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/12/2019
7:32 AM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/11/2019
3:56 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/12/2019
9:16 AM
Hadley Harbor Master Investors L.P. (0001641080) (Filed by)
Kala Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2019
8:57 AM
Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
01/07/2019
6:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2019
4:05 PM
Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
4:04 PM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
4:03 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
4:02 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/08/2018
4:07 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/01/2018
3:01 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
8:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
3:19 PM
Kala Pharmaceuticals (Subject)
Longitude Capital Partners II, LLC (Filed by)
Form SC 13D
View Filing
10/11/2018
3:11 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
3:46 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/05/2018
3:34 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/05/2018
3:33 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/05/2018
3:31 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
View Filing
10/05/2018
5:01 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/03/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
View Filing
10/02/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
View Filing
10/02/2018
3:40 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
3:38 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/05/2018
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/27/2018
11:15 PM
Kala Pharmaceuticals (Filer)
Form EFFECT
View Filing
08/23/2018
4:00 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/22/2018
12:41 PM
Kala Pharmaceuticals (Filer)
Form CT ORDER
View Filing
08/20/2018
6:07 AM
Kala Pharmaceuticals (Filer)
Form S-3/A
View Filing
08/15/2018
7:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/10/2018
8:41 AM
Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
08/09/2018
4:27 PM
Kala Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
08/09/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/09/2018
6:10 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/15/2018
9:51 AM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
9:50 AM
Kala Pharmaceuticals (Issuer)
LANGER ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
3:57 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/14/2018
3:47 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
3:47 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
3:47 PM
Hill Paulina (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
3:46 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
3:46 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2018
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2018
3:07 PM
Kala Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/25/2018
3:01 PM
Kala Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/19/2018
9:24 AM
Kala Pharmaceuticals (Filer)
Form CT ORDER
View Filing
04/09/2018
4:28 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/09/2018
4:23 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/02/2018
3:04 PM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
04/02/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/26/2018
6:06 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
7:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2018
7:07 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/02/2018
4:28 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:23 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/02/2018
4:19 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
4:13 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D
View Filing
02/13/2018
3:10 PM
Kala Pharmaceuticals (Subject)
THIRD ROCK VENTURES LP (Filed by)
Form SC 13G
View Filing
02/09/2018
3:29 PM
Kala Pharmaceuticals (Issuer)
LaRussa Michele (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/06/2018
4:05 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
4:45 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/30/2018
2:34 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2018
7:59 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/12/2018
4:29 PM
ISALY SAMUEL D (Reporting)
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/12/2018
4:03 PM
Kala Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
View Filing
01/12/2018
3:27 PM
ISALY SAMUEL D (Reporting)
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/08/2018
7:43 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
6:16 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Featured Article: What is an SEC Filing?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel